Concepedia

3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity

Hsueh‐Yun Lee, Jiann-Fong Lee, Sunil Kumar, Yi-Wen Wu, Wei‐Chun HuangFu, Mei-Jung Lai, Yu-Hsuan Li, Hsiang-Ling Huang, Fei-Chiao Kuo, Che‐Jen Hsiao,

European Journal of Medicinal Chemistry · 2016 · 41 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Madeleine Duvic, Rakshandra Talpur, Xiao Ni et al. · Blood · 2006 · 1.1K citations · Full text

, , +13

BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity<b><i>in Vivo</i></b>

Ching‐Chuan Kuo, Hsing‐Pang Hsieh, Wen-Yu Pan et al. · Cancer Research · 2004 · 200 citations

, , +8

Concise Synthesis and Structure−Activity Relationships of Combretastatin A-4 Analogues, 1-Aroylindoles and 3-Aroylindoles, as Novel Classes of Potent Antitubulin Agents

Jing‐Ping Liou, Yi-Ling Chang, Fu‐Ming Kuo et al. · Journal of Medicinal Chemistry · 2004 · 157 citations · Full text

, , +7

Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors

William Guerrant, Vishal Patil, Joshua C. Canzoneri et al. · Journal of Medicinal Chemistry · 2012 · 147 citations · Full text

, , +16

Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies

Xiaozhong Qian, William J. LaRochelle, Gulshan Ara et al. · Molecular Cancer Therapeutics · 2006 · 134 citations

, , +17